IBMS Congress 2025

Dr Victoria Bradley

Reader in Biomedical Science Clinical Practice Education, Cardiff Metropolitan University

Victoria began her career in Biomedical Science as a trainee at Southport and Formby District General Hospital whilst undertaking a part-time degree at Liverpool John Moores University. Following a move to Morriston Hospital in Swansea she undertook a Masters in Biomedical Science, specialising in Clinical Chemistry, at the University of the West of England. She was appointed as the Chemical Pathology training manager for Swansea Bay Health Board in 2008 and completed a professional doctorate in Biomedical Science in 2013 at Portsmouth University.

In 2015 she made the move to academia, taking up a lecturers post at Cardiff Metropolitan University, and in 2021 was appointed as Programme Director for Healthcare Science (Life Sciences). In 2023 she was awarded the position of Reader in Biomedical Science Clinical Practice Education in recognition of the work undertaken throughout her career.

Sheri Scott CSci FIBMS SFHEA

Principal Lecturer in Biomedical Science and IBMS Council Member, Nottingham Trent University

Sheri is a Principal Lecturer in Biomedical Science at Nottingham Trent University.

After a career covering 22 years working in Clinical Biochemistry in NHS laboratories, Sheri joined Nottingham Trent University in 2018, where she is a Principal Lecturer in Biomedical Science.

Sheri was the IBMS HSD Chief Examiner 2020-2024 for the Clinical Chemistry discipline and she continues to support clinical laboratory training through her IBMS Clinical Chemistry Specialist advisory panel and Council roles. Sheri is an active fellow and council member of the Institute of Biomedical Science.

Nicola Rouse

Lecturer in biomedical science, Open University

Nicola Rouse is a lecturer in biomedical science with a strong passion for teaching, professional development, and career progression within the field.

With 17 years of experience as an HCPC-registered biomedical scientist specialising in haematology and transfusion, Nicola has held senior roles, including eight years as a departmental training lead. She has extensive experience supporting professional development through IBMS portfolio qualifications, serving as both a Registration Portfolio Verifier and Specialist Portfolio Examiner. In these roles, she has developed learning materials, designed documentation to meet IBMS requirements, collaborated with local universities to inform course content, and participated in IBMS accreditation events.

Nicola is a Fellow of the IBMS, a Chartered Scientist, and a Fellow of the Higher Education Academy (FHEA). She holds an MSc in biomedical science, a postgraduate certificate in teaching, and qualifications in assessment, allowing her to teach across multiple levels, from NVQ Level 3 to postgraduate study. She is also a member of the haematology advisory group for the International Federation of Biomedical Laboratory Scientists.

Nicola is particularly passionate about raising awareness of red cell disorders, including sickle cell and thalassaemia, to reduce stigma and promote screening. She works to educate and encourage individuals from high-risk communities to “know their status” when planning a family, ensuring early identification of carrier status. This approach leads to better health outcomes for mothers and babies, as early intervention can prevent many complications associated with these conditions.

Nicola is a strong advocate for authentic learning design and assessment, ensuring that biomedical scientists are equipped to meet the current and future needs of patients. With pathology laboratories contributing to over 70% of all medical diagnoses, she emphasises the crucial role of biomedical scientists in healthcare.

She is also committed to making higher education more inclusive and accessible, supporting diversity in the biomedical science workforce and empowering students from all backgrounds to reach their full potential, as well as championing diversifying the UK’s blood donor pool to better support patients requiring lifelong transfusions for conditions such as sickle cell disease.